Skip to main content

Table 2 CFIR barriers and facilitators during implementation period (n = 40)

From: Use of a multi-phased approach to identify and address facilitators and barriers to the implementation of a population-wide genomic screening program

 

Facilitator

Barrier

n

%

n

%

Intervention characteristics

 Intervention source

3

7.5

2

5

 Evidence, strength, and quality

2

5

0

0

 Relative advantage

0

0

0

0

 Adaptability

21

52.5

8

20

 Trialability

9

22.5

2

5

 Complexity

2

5

14

35

 Design, quality, and packaging

8

20

5

12.5

 Cost

3

7.5

6

15

Outer setting

 Patient needs and resources

10

25

9

22.5

 Cosmopolitanism

8

20

2

5

 Peer pressure

3

7.5

1

2.5

 External policies and incentives

4

10

6

15

Inner setting

 Structural characteristics

3

7.5

6

15

 Networks and communication

19

47.5

7

17.5

 Culture

1

2.5

1

2.5

Inner setting—implementation climate

 Tension for change

5

12.5

5

12.5

 Compatibility

4

10

11

27.5

 Relative priority

10

25

1

2.5

 Organizational incentives and rewards

1

2.5

0

0

 Goals and feedback

6

15

2

5

 Learning climate

6

15

1

2.5

Inner setting—readiness for implementation

 Leadership engagement

16

40

5

12.5

 Availability of resources

11

27.5

7

17.5

 Access to knowledge and information

2

5

4

10

Characteristics of individuals

 Knowledge and beliefs about intervention

5

12.5

6

15

 Self-efficacy

6

15

9

22.5

 Individual stage of change

0

0

0

0

  1. Barriers and facilitators were assessed in real time by project staff in workgroup meetings (N = 40) during the implementation period using a CFIR-guided tracking form